« Previous Next » Leukemia Research
Volume 27, Issue 3 , Pages 259-266 , March 2003

N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL)

Stefan Faderl
- Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, P.O. Box 428, 1515 Holcombe Blvd., Houston, TX 77030, USA
Reuben Lotan
- Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, P.O. Box 422, 1515 Holcombe Blvd., Houston, TX 77030, USA
Hagop M. Kantarjian
- Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, P.O. Box 428, 1515 Holcombe Blvd., Houston, TX 77030, USA
David Harris
- Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, P.O. Box 422, 1515 Holcombe Blvd., Houston, TX 77030, USA
Quin Van
- Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, P.O. Box 422, 1515 Holcombe Blvd., Houston, TX 77030, USA
Zeev Estrov
- Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, P.O. Box 422, 1515 Holcombe Blvd., Houston, TX 77030, USA
- Corresponding author. Tel.: +1-713-794-1675; fax: +1-713-745-2374.